About this trial
1. Elucidate the influence of intense light therapy pretreatment in patients undergoing cardiac surgery. We hypothesize that intense light exposure is associated with the peripheral stabilization of Per2 in human buccal swabs and plasma samples before surgery and with a decrease of Troponin I levels after surgery. In addition, we hypothesize that light therapy leads to Per2 dependent metabolic optimization in the human cardiac tissue. Therefore, a small piece of human heart tissue from the right atrium will be collected during cardiac cannulation, which will be otherwise discarded. 2. Critical illness (being in the intensive care unit) results in circadian malfunction and vessels not working. Vessel function is controlled by the body's circadian clock. Intense light boosts the circadian clock and the vessel function in animal studies. Vessels not working well in critical ill patients results in a myriad of severe diseases (delirium, stroke, heart attack, organ damage etc). Thus we will test if intense light can be used to boost the circadian clock and the associated vessel function in critical ill patients.
Eligibility criteria
Qualifiers
Patients undergoing primary sternotomy cardiac surgery
Subjects in the range of 18 - 90 years old .
Patient need to be in sinus rhythm at the time of surgery.
Disqualifiers
patients <18 or >90 years old
participation in other clinical trials within the previous 30 days
pregnancy
neurological conditions that could impair weaning from ventilator support
Trial design
Treatments tested in this trial
- Day Light
- Placebo light
- ICU Intense Light
- ICU Placebo light
Treatment groups
Sponsors and collaborators
University of Colorado, Denver
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator